Catalan institute of Oncology Badalona

Badalona 8916

0 studies enrolling now · 2 studies all time

What they study most

Carcinoma, Basal Cell, Cutaneous Squamous Cell Carcinoma

Studies at this site

• Study of Adjuvant Cemiplimab Versus Placebo After Surgery and Radiation Therapy in Patients With High Risk Cutaneous Squamous Cell Carcinoma — Running, not enrolling
• PD-1 in Patients With Advanced Basal Cell Carcinoma Who Experienced Progression of Disease on Hedgehog Pathway Inhibitor Therapy, or Were Intolerant of Prior Hedgehog Pathway Inhibitor Therapy — Completed